NCT01307189View on ClinicalTrials.gov

Effects of Tiotropium on Walking Capacity in Patients With COPD

PHASE4CompletedINTERVENTIONAL

Enrollment

33

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

August 31, 2010

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Tiotropium

Tiotropium diskus inhalation powder, 18ug, once daily

DRUG

Placebo

Placebo diskus inhalation powder, once daily

Trial Locations (1)

G1V 4G5

Centre de recherche de l'IUCPQ, Québec

Sponsors

Collaborators (1)

Boehringer Ingelheim

All Listed Sponsors

collaborator

Boehringer Ingelheim

INDUSTRY

lead

Laval University

OTHER

NCT01307189 - Effects of Tiotropium on Walking Capacity in Patients With COPD | Biotech Hunter | Biotech Hunter